Kelsey Tsai
Investitore di Private Equity presso 213 Management LLC
Profilo
Kelsey Tsai is a Vice President for Sandbox Healthcare.
She supports the Blue Venture Fund’s investments in Thrive (now Exact Sciences), Onc.AI, Sempre Health, AbleTo and Workit Health.
Prior to Sandbox, Kelsey was an MBA associate at ARCH Venture Partners, as well as an Innovation Fund associate for the University of Chicago’s seed stage tech and life sciences fund.
Kelsey started her career as a biotech equity research analyst at Morningstar.
Kelsey holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Georgetown University.
She is also a CFA charterholder.
Posizioni attive di Kelsey Tsai
Società | Posizione | Inizio |
---|---|---|
213 Management LLC
213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Investitore di Private Equity | 01/10/2021 |
Formazione di Kelsey Tsai
The University of Chicago Booth School of Business | Masters Business Admin |
Georgetown University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
213 Management LLC
213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Finance |
- Borsa valori
- Insiders
- Kelsey Tsai